Re: [Patents] Hungary protests planned extension of data exclusivity period for pharma products in EU

[Jozef Halbersztadt <halber@idea.net.pl>]

Hartmut Pilch wrote:

> > According to current rules, member states' registration authorities
> > cannot approve generic drugs whose application refers to original drugs
> > that were authorized less than six years ago. The planned modification,
> > under discussions in the European Parliament since June, would extend
> > this period to ten years, and would be applicable to new member states
> > as well once they enter the EU next May.
> >    
>
> [...] 
>
>  
>
> > Extending the data exclusivity period could create better conditions for
> > innovation, Szekely said, adding that research and development of a new
> > product normally costs an innovative producer USD 600-800 million over a
> > typical period of 10-15 years. "Sooner or later, Hungarian producers
> > will also have original products; then, they will have the loudest voice
> > defending patents," Szekely noted.
> >    
>
> How is "data exclusivity period" related to patents?
>
> Does the period only apply to drugs which are covered by patents?
>
> Or is Szekely confusing something?
>
>  
As I understand Hungary is against extension of period of supplementary 
patent protection from 5 to 10 years. The European regulation is here 
http://europa.eu.int/scadplus/leg/en/lvb/l21156.htm

Jozef Halbersztadt